Juvenile Idiopathic Arthritis: A Review of Novel Diagnostic and Monitoring Technologies

Amelia J Garner1, Reza Saatchi2, Oliver Ward3

  • 1The Medical School, University of Sheffield, Sheffield S10 2TN, UK.

Insights

Juvenile idiopathic arthritis (JIA) diagnosis and monitoring can be improved with new tools. Novel techniques show promise for assessing JIA, but further research is needed for clinical use.

Area of Science:

  • Pediatric Rheumatology
  • Medical Diagnostics
  • Biomedical Engineering

Background:

  • Juvenile idiopathic arthritis (JIA) is a common childhood rheumatic disease with chronic, relapsing-remitting inflammation.
  • JIA can lead to joint damage, pain, and functional disability, highlighting the need for early diagnosis and effective management.
  • Current diagnostic and monitoring methods for JIA require continuous improvement to address its progressive nature.

Purpose of the Study:

  • To review recent studies on the diagnosis, monitoring, and management of JIA.
  • To outline novel tools and techniques with potential value in JIA assessment and monitoring.
  • To evaluate the emerging role of innovative technologies in clinical practice for JIA.

Main Methods:

  • Review of recent scientific literature on JIA diagnosis and management.
  • Identification and description of novel assessment and monitoring tools, including infrared thermal imaging, 3D imaging, accelerometry, artificial neural networks, and fuzzy logic.
  • Analysis of the demonstrated potential of these techniques in JIA evaluation.

Main Results:

  • Several novel techniques, including infrared thermal imaging and AI-based methods, show potential for aiding JIA diagnosis and monitoring.
  • These advanced tools may offer objective and quantitative measures to supplement traditional clinical assessments.
  • The reviewed studies indicate a promising trend towards technologically enhanced JIA management.

Conclusions:

  • Emerging technologies present a promising avenue for improving the diagnosis and monitoring of JIA.
  • These novel tools have the potential to enhance clinical decision-making and patient outcomes in JIA care.
  • Further research is essential to validate the clinical utility and widespread adoption of these innovative techniques in JIA management.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
109
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.5K
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
19
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
81
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
57
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
35